ŠLŠtefan Lukačín

Štefan Lukačín

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Štefan Lukačín has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Adrián Kolesár

    Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty, Pavol Jozef Šafárik University, 04011 Košice, Slovakia

    7 shared publications
  • Tomáš Toporcer

    Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty, Pavol Jozef Šafárik University, 04011 Košice, Slovakia

    6 shared publications
  • Anton Bereš

    Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty, Pavol Jozef Šafárik University, 04011 Košice, Slovakia

    5 shared publications
  • Marián Homola

    Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty, Pavol Jozef Šafárik University, 04011 Košice, Slovakia

    5 shared publications
  • Michal Trebišovský

    Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty, Pavol Jozef Šafárik University, 04011 Košice, Slovakia

    5 shared publications
  • Adrián Kolesár

    Klinika srdcovej chirurgie Východoslovenský ústav srdcových cievnych chorôb a. s Košice Slovenská republika

    2 shared publications

Latest Publications

  • Open Access

    Autologous Pericardial Cusps Within a Tubularized Bovine Pericardial Conduit for Right Ventricular Outflow Tract Reconstruction During the Modified Ross Procedure: A Technical Note

    by Tomáš Toporcer, Lukáš Vajda, Anton Bereš, Jaroslav Benedík, Marián Homola, Michal Trebišovský, Peter Šafár, Štefan Lukačín, Vilém Rohn, Adrián Kolesár

    Background/Objectives: Limited availability of pulmonary homografts may restrict right ventricular outflow tract reconstruction after the Ross procedure. This technical note describes the geometric construction of a valved conduit composed of autologous pericardial cusps and a tubularized bovine pericardial patch. Methods: Autologous pericardium (approximately 10 × 8 cm) is treated with 0.9% glutaraldehyde for 10 min, and three size-4 cusps with triangular ears are fashioned using a Fehling template. A bovine pericardial patch (14 × 9 cm) is marked with the cusp attachment baseline, the commissural fixation line, and asymmetric tubularization lines. The cusp implantation field is divided into three equal segments, and each cusp is sutured to the mesothelial surface of the patch with a continuous suture, followed by commissural fixation. The patch is then tubularized, and valve competence is assessed by saline testing. Results: The conduit was constructed in approximately 60 min, in parallel with the main operation, and implanted in four patients undergoing a modified Ross procedure in 2025. Echocardiography on the first postoperative day showed no more than trace pulmonary regurgitation and no conduit obstruction. No conduit-related complications occurred; only early postoperative follow-up is available. Conclusions: The technique allows construction of a valved conduit from autologous and bovine pericardium using widely available materials. Currently, it demonstrates technical feasibility only; hemodynamic performance, safety, and durability remain to be established in larger studies with standardized follow-up.

  • Open Access

    Secondary Staphylococcus capitis Infection of a Long-Standing Non-Coronary Sinus of Valsalva–to–Right Atrial Fistula Initially Misdiagnosed as a Gerbode Defect: A Case Report

    by Tomáš Toporcer, Marián Homola, Anton Bereš, Michal Trebišovský, Tomáš Lopuchovský, Štefan Lukačín, Adrián Kolesár

    Background: Aorto–atrial fistula is a rare pathological communication associated with diagnostic difficulties, progressive hemodynamic consequences, and potential infective complications. Methods and Results: We present a 53-year-old woman with a long-standing congenital non-coronary sinus of Valsalva–to–right atrial fistula that had been followed for nine years under the working diagnosis of a Gerbode defect. The communication was first detected at the age of 44 years during pregnancy and was managed conservatively while the patient remained largely asymptomatic. At the age of 53 years, recurrent exertional dyspnea prompted definitive reassessment. Right heart catheterization demonstrated a hemodynamically significant left-to-right shunt at the right atrial level, with a pulmonary-to-systemic blood flow (Qp/Qs) ratio of 2.1. Intraoperatively, the communication was shown to originate immediately above the non-coronary cusp and drain into the right atrium, establishing the diagnosis of a congenital aorto–right atrial fistula. A granulomatous, windsock-like endocardial lesion was identified at its right atrial opening, and Staphylococcus capitis was isolated from surgically obtained tissue. Histopathology showed nonspecific regressive changes without specific features of active infective endocarditis. The fistula was closed with an autologous pericardial patch, and intravenous flucloxacillin was administered because of probable localized infective involvement. Conclusions: This case illustrates the diagnostic difficulty of distinguishing an aorto–atrial fistula from a Gerbode defect and supports careful multimodality evaluation of the anatomical origin and flow characteristics of intracardiac shunts. Persistent high-velocity flow may contribute to endocardial injury and create a substrate for subsequent bacterial colonization, although causality cannot be established from a single case. Isolation of a low-virulence skin commensal from pathological cardiac tissue should be interpreted in the complete clinical, operative, microbiological, and histopathological context rather than automatically classified as contamination.

  • Open Access

    Modified Del Nido Cardioplegia with a 1:4 Crystalloid-to-Blood Ratio Versus Blood-Based St. Thomas Cardioplegia in Isolated Aortic Valve Replacement

    by Peter Jakub, Tomáš Toporcer, Matúš Marcin, Michal Trebišovský, Anton Bereš, Marián Homola, Štefan Lukačín, Adrián Kolesár

    The aim of this study was to retrospectively compare modified Del Nido and blood-based St. Thomas cardioplegia in adult patients undergoing isolated aortic valve replacement (AVR). This retrospective study included adult patients undergoing isolated AVR because of aortic valve stenosis between 2024 and 2025. Patients were stratified into blood-based St. Thomas and modified Del Nido groups. The main modification of the Del Nido solution was the adjustment of the crystalloid-to-blood ratio to 1:4. Preoperative and perioperative variables, as well as postoperative biomarkers, including high-sensitivity troponin I, creatine kinase (CK), CK-MB, and lactate, were analyzed. A total of 93 patients were included in the study (blood-based St. Thomas: n = 22; modified Del Nido: n = 71). No significant differences were observed in cardiopulmonary bypass time [98 min (IQR 84–110) vs. 90 min (IQR 74–110); p = 0.184] or aortic cross-clamp time [75 min (IQR 67–86) vs. 73 min (IQR 62–87); p = 0.345]. High-sensitivity troponin I levels at 24 h were numerically, but not statistically significantly, lower in the blood-based St. Thomas group [1961 ng/L (IQR 1367–4423) vs. 2819 ng/L (IQR 1698–5054); p = 0.240]. CK levels at 6 h were comparable between the groups [8.4 μkat/L (IQR 6.5–10.1) vs. 8.5 μkat/L (IQR 6.0–12.7); p = 0.632], as were CK-MB and lactate levels at all evaluated time points. In exploratory multivariable analyses adjusted for age, sex, preoperative LVEF, cardiopulmonary bypass time, and aortic cross-clamp time, cardioplegia type was not independently associated with postoperative biomarker levels. The less frequent dosing and membrane-stabilizing properties of modified Del Nido cardioplegia did not translate into statistically significant clinical or biochemical advantages in the setting of relatively short, isolated AVR procedures.

  • Open Access

    Early Aortic Autograft Infective Endocarditis with Perivalvular Abscess Following the Ross Procedure

    by Peter Snopek, Štefan Lukačín, Ingrid Schusterová, Adrián Kolesár, Jozef Hasilla, Milan Klačanský, Pavol Fülöp, Tibor Porubän, Štefan Tóth, Mariana Dvorožňáková

    Background: The Ross procedure provides excellent outcomes in young adults requiring aortic valve replacement, with lower rates of infective endocarditis (IE) compared to prosthetic valves. Early postoperative IE of the autograft is exceptionally rare, with only isolated cases reported in major registries. Case Summary: We report a 40-year-old man with bicuspid aortic valve and a history of two previous episodes of native valve endocarditis who underwent Ross procedure with Ozaki modification. Ten days postoperatively, he developed fever and was diagnosed with early autograft IE with perivalvular abscess formation. Despite negative blood cultures (due to prior antibiotic administration), clinical findings met modified Duke criteria for possible IE. Imaging revealed perivalvular abscess with subsequent pseudoaneurysm development, while the autograft leaflets remained functional. The patient was successfully treated with 6-week combination antibiotic therapy without requiring surgical reintervention. After one year of follow-up, he remains asymptomatic with stable pseudoaneurysm size and preserved valvular function. Conclusions: Early IE following Ross procedure, though rare, should be considered in patients presenting with postoperative fever. This case demonstrates that conservative management with appropriate antibiotic therapy can be successful even with perivalvular complications, provided there is hemodynamic stability and close multidisciplinary monitoring. Long-term surveillance remains essential given the persistent structural abnormalities.

  • Open Access

    (Minimally Invasive Mitral Valve Surgery via Video-Assisted Thoracotomy - A Single Center Study)

    by Marián Homola, Štefan Lukačín, Tomáš Toporcer, Anton Bereš, Michal Trebišovský, Peter Šafár, Adrián Kolesár

    Miniinvaz?vna chirurgia mitr?lnej chlopne (MIMVS), pomocou videoasistovanej torakoskopie (VATS), sa etablovala ako efekt?vny pr?stup v kardiochirurgii za posledn?ch 30 rokov. Tento typ oper?cie umo??uje men?ie rezy, ?o vedie k r?chlej?ej rekon...

  • Open Access

    Thoracic aortic aneurysm with an aberrant right subclavian artery and truncus bicaroticus

    by Carlos Daniel Quintana Baños, Štefan Lukačín, Tomáš Toporcer, Adrián Kolesár, Matej Moščovič, Peter Šafár

    ?vod: Arteria lus?ria, alebo aberantn? prav? arteria subclavia (ARSA), je anom?lia supraaort?lnych vetiev aorty s v?skytom 0,2 - 1,7 percenta. U 8 % pacientov s ARSA sa rozvinie aneuryzma hrudnej aorty, v porovnan? s v?skytom 4,4 % v popul?cii...

  • Open Access

    Short-Term Outcomes of Partial Upper Ministernotomy for Aortic Valve Replacement Within the Learning Curve Context

    by Tomáš Toporcer, Marián Homola, Anton Bereš, Michal Trebišovský, Tomáš Lopuchovský, Štefánia Mižáková, Lukáš Vajda, Štefan Lukačín, Adrián Kolesár

    Background: In recent decades, aortic valve surgery has transitioned from conventional median sternotomy (MS) to minimally invasive techniques, including partial upper mini-sternotomy (PUMS) and right anterolateral mini-thoracotomy (RAMT). This study retrospectively compares the outcomes of aortic valve replacement (AVR) using PUMS during the learning phase with those of standard MS. Methods: A retrospective analysis was conducted on patients (n = 211) who underwent AVR for aortic stenosis. They were divided into MS (n = 119) and PUMS (n = 92) groups. Various preoperative, surgical and postoperative parameters, including survival, were examined. Results: Preoperatively, the main difference was age, with PUMS patients being older (67.5 ± 7 vs. 66.5 ± 9.6; p = 0.010). PUMS patients also had longer cardiopulmonary bypass (CPB) and cross-clamping times (99 ± 25 vs. 80 ± 16 min; p < 0.002; 79 ± 18 vs. 65 ± 13 min; p < 0.024). There were no significant differences in body mass index, prosthesis size, indexed effective orifice area, hospitalisation duration or any other monitored parameter. Echocardiographic follow-up found no differences in prosthetic pressure gradients, flow velocity or paravalvular leak between the PUMS and MS groups. Survival rates were similar over 1000 days. Conclusions: The data suggest that PUMS offers comparable surgical outcomes to MS for AVR with additional cosmetic benefits, undeterred by a learning curve.


  • Open Access

    Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates

    by Tomáš Toporcer, Štefan Lukačín, Andrea Kraus, Marián Homola, Anton Bereš, Michal Trebišovský, Denis Radótzy, Vilém Rohn, Adrián Kolesár

    Background: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients aged 50–65 years after AVR. Methods: The retrospective analysis included 276 patients aged 50 to 65 years who had undergone isolated AVR for AoS; 161 patients were implanted with an MP and 115 with a BP. Patient survival, adjusted for age, gender and risk parameters affecting survival, was assessed. A subgroup analysis was performed on the 208 patients with a modern valve (prosthesis models that are no longer used in clinical practice were removed from the sample). Results: After adjusting for risk factors for overall survival as well as for age and sex, the implantation of an MP did not have a significant effect on overall survival in comparison to a BP, at a median follow-up of 10.3 years (p = 0.477). The size of the MP had no significant effect on overall survival either (HR: 1.29; 95%CI: 0.16–10.21; p = 0.812). However, the indexed effective orifice area of the BP had a positive effect on overall survival (HR: 0.09; 95%CI: 0.01–0.78; p = 0.029). Conclusions: The estimated survival of patients aged between 50 and 65 years after implantation of a BP with a sufficiently large indexed effective orifice area may exceed that of patients with an MP.


  • Open Access

    Anomalous Arising of Right Coronary Artery from the Pulmonary Artery

    by Adrián Kolesár, Tomáš Toporcer, Jana Čobejová, Štefan Lukačin

    Coronary artery anomalies are seen in less than 1% of the general population and in 1.6% of cardiac catheterization cases. The anomalous origin of the coronary artery from the pulmonary artery is one of four groups of coronary artery origin anomalies. The incidence of anomalous origin of the right coronary artery from the pulmonary artery is 1 in 500,000 and was first described in 1882 by John Brook. This case report reports on a 67-year-old man with a diagnosis of asymptomatic anomalous origin of the right coronary artery from the pulmonary artery. The patient underwent surgery of the aortic valve because of valve stenosis. A concomitant surgical procedure included repositioning of the right coronary artery origin to the aortic root sinus. The patient was discharged on the 12th postoperative day, in good condition. Anomalous origin of the right coronary artery from the pulmonary artery is commonly asymptomatic, and surgery is required only if myocardial ischemia is presented.


  • Open Access

    Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis

    by Lukáš Urban, Matúš Čoma, Lukáš Lacina, Pavol Szabo, Jana Sabová, Tomáš Urban, Hubert Šuca, Štefan Lukačín, Robert Zajíček, Karel Smetana, et al.

    Identification of therapeutic targets for treating fibrotic diseases and cancer remains challenging. Our study aimed to investigate the effects of TGF-β1 and TGF-β3 on myofibroblast differentiation and extracellular matrix deposition in different types of fibroblasts, including normal/dermal, cancer-associated, and scar-derived fibroblasts. When comparing the phenotype and signaling pathways activation we observed extreme heterogeneity of studied markers across different fibroblast populations, even within those isolated from the same tissue. Specifically, the presence of myofibroblast and deposition of extracellular matrix were dependent on the origin of the fibroblasts and the type of treatment they received (TGF-β1 vs. TGF-β3). In parallel, we detected activation of canonical signaling (pSMAD2/3) across all studied fibroblasts, albeit to various extents. Treatment with TGF-β1 and TGF-β3 resulted in the activation of canonical and several non-canonical pathways, including AKT, ERK, and ROCK. Among studied cells, cancer-associated fibroblasts displayed the most heterogenic response to TGF-β1/3 treatments. In general, TGF-β1 demonstrated a more potent activation of signaling pathways compared to TGF-β3, whereas TGF-β3 exhibited rather an inhibitory effect in keloid- and hypertrophic scar-derived fibroblasts suggesting its clinical potential for scar treatment. In summary, our study has implications for comprehending the role of TGF-β signaling in fibroblast biology, fibrotic diseases, and cancer. Future research should focus on unraveling the mechanisms beyond differential fibroblast responses to TGF-β isomers considering inherent fibroblast heterogeneity.